Marco Del Chiaro MD, PhD, FACSProfessor and Division Chief of Surgical Oncology; Morton and Sandra Saffer Endowed Chair; Director, University of Colorado HPB Program; Director, University of Colorado NPF Designated Center of Excellence for Pancreatic Cancer, Department of Surgery, University of Colorado School of Medicine; Cancer Center, University of Colorado School of Medicine, Aurora, Colorado
Dr. Del Chiaro is Professor of Surgery and Division Chief of Surgical Oncology at the University of Colorado Anschutz Medical Campus. He is an academic surgical oncologist specializing in pancreatic disease. He is internationally recognized as a leader in the surgical treatment of borderline resectable/locally advanced pancreatic cancer and treatment of precursor lesions of pancreatic cancer. He is the PI of the evidence-based European guidelines on pancreatic cystic tumors.
Dr. Del Chiaro discloses receiving an industry grant (Haemonetics, Inc) to conduct a multicenter study to evaluate the prognostic implications of TEG in pancreatic cancer and being co-principal investigator of a Boston Scientific sponsored international multicenter study on the use of intraoperative pancreatoscopy of patients with IPMN.